Showing results (2101-2110 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|February 24, 2024
Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination StrategyChing-Hao Lin, Tsung-An Chen, Pin-Hsuan Chiang, et al.
Vaccines|February 24, 2024
COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple SclerosisIgnacio Hernández-García, Joana Rodríguez-Montolio, Monserrath Almeida-Zurita, et al.
Vaccines|February 24, 2024
Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity StudiesMaysa Santos Barbosa, Beatriz Almeida Sampaio, Joachim Spergser, et al.
Vaccines|February 24, 2024
Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces-Vietnam, 2017-2021Ly Khanh Thi Le, Thao Phuong Thi Pham, Le Thi Phuong Mai, et al.
Vaccines|February 24, 2024
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria TransmissionDoreen D Mutemi, James Tuju, Rodney Ogwang, et al.
Vaccines|February 24, 2024
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-AnalysisMilena Adina Man, Daniela Rosca, Felix Bratosin, et al.
Vaccines|February 24, 2024
Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP VaccineXin Tong, Jessica Raffaele, Katrina Feller, et al.
Vaccines|February 24, 2024
The Importance of Natural and Acquired Immunity to SARS-CoV-2 Infection in Patients on Peritoneal DialysisMarko Baralić, Mirjana Laušević, Danica Ćujić, et al.
Vaccines|February 24, 2024
Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in EnglandKhitam Muhsen, Pauline A Waight, Freja Kirsebom, et al.
Vaccines|April 27, 2024
Correction: Isa et al. HSV-1 ICP22 Is a Selective Viral Repressor of Cellular RNA Polymerase II-Mediated Transcription Elongation. Vaccines 2021, 9, 1054Nur Firdaus Isa, Olivier Bensaude, Nadiah C Aziz, et al.
Pageof 1,039